SLITRK4 and colorectal carcinoma: Furthermore, using SLITRK4‐knockout and SLITRK4‐overexpressing CRC cell lines and mouse models, we confirmed that SLITRK4 exerted protumorigenic effects by enhancing tumor growth, invasion, and liver metastasis.